Renalytix Plc specializes in developing artificial intelligence-driven in vitro diagnostic solutions for kidney diseases. Its flagship offering, KidneyIntelX, is a sophisticated diagnostic platform. This system leverages an AI-powered algorithm that integrates diverse data inputs, including validated blood-based biomarkers, an individual's inherited genetics, and personalized patient data extracted from electronic health records, to generate a unique risk score for each patient.